[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Tamsulosin.]
[J01GA01, streptomycin, Tamsulosin may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01CG01, sulbactam, Tamsulosin may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Tamsulosin.]
[J01EC01, sulfamethoxazole, The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Tamsulosin.]
[S01AB02, sulfisoxazole, The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Tamsulosin.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be increased when used in combination with Tamsulosin.]
[A10BC01, glymidine, The therapeutic efficacy of Glymidine can be increased when used in combination with Tamsulosin.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Tamsulosin.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Tamsulosin.]
[B01AE07, dabigatran etexilate, Tamsulosin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Tamsulosin.]
[S03AA02, tetracycline, Tamsulosin may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05AE05, lurasidone, Tamsulosin may increase the hypotensive activities of Lurasidone.]
[A04AD10, dronabinol, The metabolism of Tamsulosin can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Tamsulosin.]
[P02CA02, thiabendazole, Tamsulosin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Tamsulosin.]
[N05AB08, thioproperazine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Thioproperazine.]
[N05AC02, thioridazine, Thioridazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Tamsulosin.]
[G04BE06, moxisylyte, Tamsulosin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Tamsulosin may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Tamsulosin can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, Timolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[P01AB02, tinidazole, Tamsulosin may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Tamsulosin may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be increased when used in combination with Tamsulosin.]
[M02AX02, tolazoline, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tolazoline.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be increased when used in combination with Tamsulosin.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AF04, tranylcypromine, The metabolism of Tamsulosin can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, Trazodone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Tretinoin.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Tamsulosin may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Tamsulosin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trifluoperazine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A03AA05, trimebutine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Trimebutine.]
[N03AC02, trimethadione, The risk or severity of hypotension can be increased when Tamsulosin is combined with Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AA06, trimipramine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trimipramine.]
[R06AC04, tripelennamine, The metabolism of Tamsulosin can be decreased when combined with Tripelennamine.]
[J01FA08, troleandomycin, The metabolism of Tamsulosin can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Tamsulosin can be decreased when combined with Vilazodone.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Tamsulosin may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Tamsulosin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Tamsulosin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Tamsulosin can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Tamsulosin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Tamsulosin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Tamsulosin can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Tamsulosin can be decreased when combined with Rilpivirine.]
[S01AA28, vancomycin, Tamsulosin may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Tamsulosin may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Tamsulosin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The therapeutic efficacy of Indacaterol can be decreased when used in combination with Tamsulosin.]
[C08DA01, verapamil, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[N06AX09, viloxazine, The metabolism of Tamsulosin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Tamsulosin can be decreased when combined with Vinblastine.]
[C04AX07, vincamine, Tamsulosin may increase the hypotensive activities of Vincamine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[B01AA03, warfarin, Tamsulosin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[S01AA13, fusidic acid, The metabolism of Tamsulosin can be decreased when combined with Fusidic acid.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Tamsulosin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Tamsulosin can be decreased when combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M05BA05, tiludronic acid, Tamsulosin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Tamsulosin may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Tamsulosin can be decreased when combined with Crizotinib.]
[A02BC04, rabeprazole, Tamsulosin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N05AE04, ziprasidone, Ziprasidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Tamsulosin may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Tamsulosin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Tamsulosin may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Tamsulosin may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[J02AC03, voriconazole, The metabolism of Tamsulosin can be decreased when combined with Voriconazole.]
[M01CB03, auranofin, Tamsulosin may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Tamsulosin may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Tamsulosin may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Tamsulosin may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[G04BE10, avanafil, Tamsulosin may increase the hypotensive activities of Avanafil.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A08AA11, lorcaserin, The metabolism of Tamsulosin can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Tamsulosin can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Tamsulosin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Tamsulosin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Tamsulosin can be decreased when it is combined with Enzalutamide.]
[C01CA18, octopamine, The therapeutic efficacy of Octopamine can be decreased when used in combination with Tamsulosin.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Tamsulosin.]
[D02BA02, octinoxate, Tamsulosin may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Tamsulosin can be decreased when combined with Nelfinavir.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Tamsulosin.]
[C08CA13, lercanidipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Tamsulosin.]
[G04BD10, darifenacin, The metabolism of Tamsulosin can be decreased when combined with Darifenacin.]
[V09IX04, fluorodeoxyglucose F18, Tamsulosin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The risk or severity of hypotension and syncope can be increased when Sildenafil is combined with Tamsulosin.]
[V08CA11, gadofosveset, Tamsulosin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Tamsulosin.]
[A16AX08, teduglutide, Tamsulosin may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, The risk or severity of hypotension can be increased when Tamsulosin is combined with Bencyclane.]
[A10BH04, alogliptin, The therapeutic efficacy of Alogliptin can be increased when used in combination with Tamsulosin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Tamsulosin can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Tamsulosin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[G03XC05, ospemifene, The metabolism of Tamsulosin can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be increased when used in combination with Tamsulosin.]
[A06AX06, tegaserod, The metabolism of Tamsulosin can be decreased when combined with Tegaserod.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Tamsulosin.]
[A10BX05, pramlintide, The therapeutic efficacy of Pramlintide can be increased when used in combination with Tamsulosin.]
[L03AA12, ancestim, Tamsulosin may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Tamsulosin can be decreased when combined with Celecoxib.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Tamsulosin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA18, everolimus, The metabolism of Tamsulosin can be decreased when combined with Everolimus.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Tamsulosin can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01EE01, trametinib, Tamsulosin may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Tamsulosin.]
[V09AX05, florbetapir F-18, Tamsulosin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Tamsulosin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, The risk or severity of hypotension can be increased when Tamsulosin is combined with Bepridil.]
[C02KX05, riociguat, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Riociguat.]
[A10BJ03, lixisenatide, The therapeutic efficacy of Lixisenatide can be increased when used in combination with Tamsulosin.]
[C02KX04, macitentan, Tamsulosin may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Tamsulosin.]
[N06AX26, vortioxetine, Tamsulosin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AP05, simeprevir, The metabolism of Tamsulosin can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Tamsulosin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Tamsulosin.]
[C01CA27, droxidopa, The therapeutic efficacy of Droxidopa can be decreased when used in combination with Tamsulosin.]
[C07AB04, acebutolol, Acebutolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[N05CH03, tasimelteon, Tamsulosin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[A16AA07, metreleptin, The metabolism of Tamsulosin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Tamsulosin can be increased when combined with Apremilast.]
[L02BG02, formestane, Tamsulosin may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, Betaxolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[V03AB34, fomepizole, Tamsulosin may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, The therapeutic efficacy of Bethanidine can be decreased when used in combination with Tamsulosin.]
[A10BJ04, albiglutide, The therapeutic efficacy of Albiglutide can be increased when used in combination with Tamsulosin.]
[L04AC11, siltuximab, The metabolism of Tamsulosin can be increased when combined with Siltuximab.]
[A10BK03, empagliflozin, The therapeutic efficacy of Empagliflozin can be increased when used in combination with Tamsulosin.]
[R03AC19, olodaterol, The therapeutic efficacy of Olodaterol can be decreased when used in combination with Tamsulosin.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A16AX10, eliglustat, The metabolism of Tamsulosin can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Tamsulosin can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05AA04, acepromazine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.]
[A10BJ05, dulaglutide, The therapeutic efficacy of Dulaglutide can be increased when used in combination with Tamsulosin.]
[N04AA02, biperiden, The metabolism of Tamsulosin can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Tamsulosin.]
[S03AA06, gentamicin, Tamsulosin may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Tamsulosin.]
[B01AF03, edoxaban, Tamsulosin may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Tamsulosin can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Tamsulosin can be increased when combined with Secukinumab.]
[L01XH03, panobinostat, The metabolism of Tamsulosin can be decreased when combined with Panobinostat.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Tamsulosin can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.]
[A04AD14, rolapitant, The metabolism of Tamsulosin can be decreased when combined with Rolapitant.]
[A10BF01, acarbose, The therapeutic efficacy of Acarbose can be increased when used in combination with Tamsulosin.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin degludec.]
[A02BC03, lansoprazole, The metabolism of Tamsulosin can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Tamsulosin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Tamsulosin.]
[J02AC05, isavuconazole, The metabolism of Tamsulosin can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Tamsulosin.]
[L01XG03, ixazomib, Tamsulosin may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Tamsulosin may increase the hypotensive activities of Selexipag.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be increased when used in combination with Tamsulosin.]
[G04CA01, alfuzosin, Tamsulosin may increase the hypotensive activities of Alfuzosin.]
[M04AB05, lesinurad, Tamsulosin may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N03AX23, brivaracetam, Tamsulosin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Tamsulosin can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Tamsulosin may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Tamsulosin may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C08CA01, amlodipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Amlodipine.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Tamsulosin.]
[C07AA19, bupranolol, Bupranolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[N07BC01, buprenorphine, The metabolism of Tamsulosin can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Arsenic trioxide.]
[M02AA03, clofezone, Tamsulosin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Tamsulosin can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Tamsulosin can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Tamsulosin can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Tamsulosin.]
[A06AH05, naldemedine, Tamsulosin may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Tamsulosin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Tamsulosin.]
[A10BX06, benfluorex, The therapeutic efficacy of Benfluorex can be increased when used in combination with Tamsulosin.]
[P01CA02, benznidazole, Tamsulosin may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Tamsulosin.]
[J05AF06, abacavir, Tamsulosin may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Tamsulosin can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, Tamsulosin may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Tamsulosin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Tamsulosin can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Tamsulosin.]
[J01MA23, delafloxacin, Tamsulosin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Tamsulosin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Tamsulosin.]
[C07AB07, bisoprolol, Bisoprolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[R03AC17, bitolterol, The therapeutic efficacy of Bitolterol can be decreased when used in combination with Tamsulosin.]
[J05AG03, efavirenz, The metabolism of Tamsulosin can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C07AA17, bopindolol, Bopindolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nesiritide.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Tamsulosin may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Tamsulosin.]
[A10BJ06, semaglutide, The therapeutic efficacy of Semaglutide can be increased when used in combination with Tamsulosin.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Tamsulosin.]
[R06AX18, acrivastine, Tamsulosin may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Captopril.]
[L02BB05, apalutamide, The metabolism of Tamsulosin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Tamsulosin can be increased when combined with Carbamazepine.]
[C07AG02, carvedilol, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension and syncope can be increased when Fostamatinib is combined with Tamsulosin.]
[N03AX24, cannabidiol, The metabolism of Tamsulosin can be decreased when combined with Cannabidiol.]
[L04AA37, baricitinib, Tamsulosin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Tamsulosin.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01GB14, plazomicin, Tamsulosin may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The therapeutic efficacy of Celiprolol can be decreased when used in combination with Tamsulosin.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Tamsulosin.]
[L01XX62, ivosidenib, The metabolism of Tamsulosin can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Tamsulosin.]
[A16AX14, migalastat, Tamsulosin may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Tamsulosin can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Tamsulosin.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be increased when used in combination with Tamsulosin.]
[N01BA04, chloroprocaine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Chloroprocaine.]
[D08AE05, chloroxylenol, Tamsulosin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Tamsulosin.]
[L04AA39, emapalumab, The metabolism of Tamsulosin can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A06AX05, prucalopride, Tamsulosin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Cilazapril.]
[B01AC23, cilostazol, Tamsulosin may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[P02BX04, triclabendazole, The metabolism of Tamsulosin can be decreased when combined with Triclabendazole.]
[J01FA09, clarithromycin, The metabolism of Tamsulosin can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Tamsulosin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, The metabolism of Tamsulosin can be decreased when combined with Clobazam.]
[C09CA06, candesartan, Tamsulosin may increase the hypotensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Tamsulosin can be increased when combined with Etanercept.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Tamsulosin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01EJ02, fedratinib, The metabolism of Tamsulosin can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Tamsulosin can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Tamsulosin.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Tamsulosin.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin pork.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N03AX25, cenobamate, The serum concentration of Tamsulosin can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Tamsulosin can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Tamsulosin may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB02, dexchlorpheniramine, The metabolism of Tamsulosin can be decreased when combined with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, Tamsulosin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[M01AX21, diacetylrhein, The metabolism of Tamsulosin can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Tamsulosin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Tamsulosin can be decreased when combined with Amprenavir.]
[R02AA03, dichlorobenzyl alcohol, Tamsulosin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Tamsulosin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Tamsulosin.]
[N02CC06, eletriptan, The metabolism of Tamsulosin can be decreased when combined with Eletriptan.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C08CA16, clevidipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Tamsulosin can be decreased when combined with Dronedarone.]
[C02AA06, methoserpidine, Tamsulosin may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Tamsulosin.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Opicapone.]
[C01CA14, dopexamine, The therapeutic efficacy of Dopexamine can be decreased when used in combination with Tamsulosin.]
[G04BD09, trospium, The metabolism of Tamsulosin can be decreased when combined with Trospium.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[V08CA05, mangafodipir, Tamsulosin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Tamsulosin.]
[C08CA17, levamlodipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Levamlodipine.]
[P01BB01, proguanil, The metabolism of Tamsulosin can be decreased when combined with Proguanil.]
[L04AC19, satralizumab, The serum concentration of Tamsulosin can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The metabolism of Oliceridine can be decreased when combined with Tamsulosin.]
[P01BA01, chloroquine, The metabolism of Tamsulosin can be decreased when combined with Chloroquine.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The metabolism of Tamsulosin can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Tamsulosin.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A11CC05, cholecalciferol, The metabolism of Tamsulosin can be decreased when combined with Cholecalciferol.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Tamsulosin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA03, choline salicylate, Tamsulosin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Vinpocetine.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[B06AC06, berotralstat, The metabolism of Tamsulosin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Tamsulosin can be decreased when combined with Lonafarnib.]
[M01AX25, chondroitin sulfates, Tamsulosin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Tamsulosin can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Vericiguat.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Fenoldopam.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N02BG07, flupirtine, Tamsulosin may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The therapeutic efficacy of Formoterol can be decreased when used in combination with Tamsulosin.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin human.]
[L03AB10, peginterferon alfa-2b, The metabolism of Tamsulosin can be decreased when combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Tamsulosin may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The serum concentration of Tamsulosin can be increased when it is combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N07CA02, cinnarizine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Tamsulosin can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Tamsulosin can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Tamsulosin may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The metabolism of Tamsulosin can be decreased when combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Tamsulosin.]
[V09AB03, ioflupane I-123, Tamsulosin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Tamsulosin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Tamsulosin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R06AA04, clemastine, The metabolism of Tamsulosin can be decreased when combined with Clemastine.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be increased when used in combination with Tamsulosin.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be increased when used in combination with Tamsulosin.]
[R03CC13, clenbuterol, The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Tamsulosin.]
[N06AX25, St. John's wort extract, The metabolism of Tamsulosin can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Tamsulosin can be decreased when combined with Ropeginterferon alfa-2b.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Levobupivacaine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Tamsulosin.]
[N03AE01, clonazepam, Tamsulosin may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Tamsulosin.]
[C01EB24, mavacamten, The serum concentration of Tamsulosin can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A10BX16, tirzepatide, The therapeutic efficacy of Tirzepatide can be increased when used in combination with Tamsulosin.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Tamsulosin.]
[N05AH02, clozapine, Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[A10BX01, guar gum, The therapeutic efficacy of Guar gum can be increased when used in combination with Tamsulosin.]
[A10BK06, sotagliflozin, The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Tamsulosin.]
[J01GB12, arbekacin, Tamsulosin may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Tamsulosin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The metabolism of Tamsulosin can be decreased when combined with Cocaine.]
[C02KB01, metyrosine, Tamsulosin may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Tamsulosin can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R05DA04, codeine, The metabolism of Tamsulosin can be decreased when combined with Codeine.]
[M04AC01, colchicine, Tamsulosin may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Tamsulosin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01XB01, colistin, Tamsulosin may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Desflurane.]
[A04AA03, tropisetron, Tamsulosin may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, The therapeutic efficacy of Nateglinide can be increased when used in combination with Tamsulosin.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[H01AC03, mecasermin, The therapeutic efficacy of Mecasermin can be increased when used in combination with Tamsulosin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Tamsulosin can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Tamsulosin.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AB14, valganciclovir, Tamsulosin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Tamsulosin may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Tamsulosin may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Tamsulosin may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Tamsulosin may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Tamsulosin may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A03AX10, isometheptene, The therapeutic efficacy of Isometheptene can be decreased when used in combination with Tamsulosin.]
[N02CC05, almotriptan, Tamsulosin may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J02AC02, itraconazole, The metabolism of Tamsulosin can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05BA10, ketazolam, Tamsulosin may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Tamsulosin can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Tamsulosin can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, Tamsulosin may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N07BC04, lofexidine, The therapeutic efficacy of Lofexidine can be decreased when used in combination with Tamsulosin.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Lisinopril.]
[A06AD01, magnesium carbonate, Tamsulosin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Tamsulosin can be decreased when combined with Manidipine.]
[C07AA14, mepindolol, Mepindolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Tamsulosin.]
[J01DH02, meropenem, Tamsulosin may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C04AX01, cyclandelate, The risk or severity of hypotension can be increased when Tamsulosin is combined with Cyclandelate.]
[R03CB02, methoxyphenamine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Methoxyphenamine.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, The metabolism of Tamsulosin can be decreased when combined with Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BF02, miglitol, The therapeutic efficacy of Miglitol can be increased when used in combination with Tamsulosin.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Tamsulosin.]
[S01XA18, cyclosporine, The risk or severity of renal failure can be increased when Tamsulosin is combined with Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Tamsulosin.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Moexipril is combined with Tamsulosin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Tamsulosin can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The therapeutic efficacy of Moxonidine can be decreased when used in combination with Tamsulosin.]
[G04BE09, vardenafil, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Tamsulosin.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01AX04, dacarbazine, Tamsulosin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Tamsulosin can be decreased when combined with Danazol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Tamsulosin.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Tamsulosin.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N07BB05, nalmefene, Tamsulosin may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, The therapeutic efficacy of Nebivolol can be decreased when used in combination with Tamsulosin.]
[S01GX04, nedocromil, Tamsulosin may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nefazodone.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Tamsulosin.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CA23, theodrenaline, Tamsulosin may decrease the hypertensive activities of Theodrenaline.]
[C01CA05, norfenefrine, The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Tamsulosin.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AB10, escitalopram, The serum concentration of Tamsulosin can be increased when it is combined with Escitalopram.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AA01, desipramine, The metabolism of Tamsulosin can be decreased when combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[V04CH02, indigo carmine, Tamsulosin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Aliskiren.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S03BA01, dexamethasone, The metabolism of Tamsulosin can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Tamsulosin can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Tamsulosin can be decreased when combined with Dexfenfluramine.]
[L04AB04, adalimumab, The metabolism of Tamsulosin can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Tamsulosin can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Tamsulosin can be decreased when combined with Dextromethorphan.]
[N06AB05, paroxetine, The metabolism of Tamsulosin can be decreased when combined with Paroxetine.]
[P03AC04, permethrin, Tamsulosin may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Tamsulosin may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Diazoxide.]
[R05DA08, pholcodine, Tamsulosin may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A03AA07, dicyclomine, Tamsulosin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Tamsulosin may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Tamsulosin may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of hypotension can be increased when Tamsulosin is combined with Pinaverium.]
[A10BG03, pioglitazone, The therapeutic efficacy of Pioglitazone can be increased when used in combination with Tamsulosin.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Pipamperone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Tamsulosin.]
[R03CC07, pirbuterol, The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Tamsulosin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Diethylpropion.]
[C08CA03, isradipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Isradipine.]
[D07XC04, diflucortolone, Tamsulosin may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01AA05, digoxin, Tamsulosin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Tamsulosin may increase the hypotensive activities of Dihydralazine.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Tamsulosin can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, Tamsulosin may increase the hypotensive activities of Treprostinil.]
[H03BC01, potassium perchlorate, Tamsulosin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Tamsulosin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[C08DB01, diltiazem, The risk or severity of hypotension can be increased when Tamsulosin is combined with Diltiazem.]
[V03AB09, dimercaprol, Tamsulosin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, The therapeutic efficacy of Procaterol can be decreased when used in combination with Tamsulosin.]
[M02AX03, dimethyl sulfoxide, The metabolism of Tamsulosin can be decreased when combined with Dimethyl sulfoxide.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R06AA02, diphenhydramine, The metabolism of Tamsulosin can be decreased when combined with Diphenhydramine.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Quinapril.]
[B01AC07, dipyridamole, The risk or severity of hypotension and syncope can be increased when Dipyridamole is combined with Tamsulosin.]
[A03FA02, cisapride, The metabolism of Tamsulosin can be decreased when combined with Cisapride.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Tamsulosin.]
[N05AL04, remoxipride, The metabolism of Tamsulosin can be decreased when combined with Remoxipride.]
[R03CC14, reproterol, The therapeutic efficacy of Reproterol can be decreased when used in combination with Tamsulosin.]
[S01AX06, resorcinol, Tamsulosin may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The therapeutic efficacy of Disopyramide can be increased when used in combination with Tamsulosin.]
[S02AA12, rifamycin SV, The metabolism of Tamsulosin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Tamsulosin can be increased when combined with Rifapentine.]
[N05AX08, risperidone, Tamsulosin may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Tamsulosin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Tamsulosin.]
[L01EX01, sunitinib, The therapeutic efficacy of Sunitinib can be increased when used in combination with Tamsulosin.]
[A04AD12, aprepitant, The metabolism of Tamsulosin can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The metabolism of Tamsulosin can be decreased when combined with Bortezomib.]
[G04BE08, tadalafil, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Tamsulosin.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C02KX02, ambrisentan, Tamsulosin may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, The serum concentration of Tamsulosin can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R03AC12, salmeterol, The therapeutic efficacy of Salmeterol can be decreased when used in combination with Tamsulosin.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CA07, dobutamine, The therapeutic efficacy of Dobutamine can be decreased when used in combination with Tamsulosin.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Tamsulosin.]
[C01CA04, dopamine, Tamsulosin may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Tamsulosin can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxepin.]
[L01DB01, doxorubicin, The metabolism of Tamsulosin can be decreased when combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AB06, sertraline, The metabolism of Tamsulosin can be decreased when combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[A08AA10, sibutramine, Tamsulosin may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The metabolism of Tamsulosin can be decreased when combined with Simvastatin.]
[A12CA02, sodium sulfate, Tamsulosin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Tamsulosin may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[V04CX07, edrophonium, Tamsulosin may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Talinolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[L01AX03, temozolomide, Tamsulosin may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[G04CA03, terazosin, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Tamsulosin can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, The risk or severity of hypotension can be increased when Tamsulosin is combined with Terodiline.]
[C07AA16, tertatolol, Tertatolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[S01GA02, tetrahydrozoline, The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Tamsulosin.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Enalapril is combined with Tamsulosin.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Tamsulosin.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Tamsulosin.]
[N05CC01, chloral hydrate, Tamsulosin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[R03CC11, tulobuterol, The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Tamsulosin.]
[C02CA06, urapidil, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Urapidil.]
[L01CA04, vinorelbine, The metabolism of Tamsulosin can be decreased when combined with Vinorelbine.]
[S01FB02, ephedrine, The therapeutic efficacy of Ephedrine can be decreased when used in combination with Tamsulosin.]
[S01GX10, epinastine, The metabolism of Tamsulosin can be decreased when combined with Epinastine.]
[N06AX16, venlafaxine, The metabolism of Tamsulosin can be decreased when combined with Venlafaxine.]
[C01CX07, xamoterol, The therapeutic efficacy of Xamoterol can be decreased when used in combination with Tamsulosin.]
[S01GA03, xylometazoline, The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Tamsulosin.]
[C08CA12, mepirodipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Barnidipine.]
[S01EA01, epinephrine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Tamsulosin.]
[C09AA15, zofenopril, Tamsulosin may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, The metabolism of Tamsulosin can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N03AX15, zonisamide, The risk or severity of hypotension can be increased when Tamsulosin is combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin glulisine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C02AC02, guanfacine, The therapeutic efficacy of Guanfacine can be decreased when used in combination with Tamsulosin.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Iloprost.]
[G02AB03, ergonovine, The therapeutic efficacy of Ergometrine can be decreased when used in combination with Tamsulosin.]
[N02CA02, ergotamine, Ergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[L03AX05, pidotimod, Tamsulosin may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Tamsulosin can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Tamsulosin may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Tamsulosin can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, Tamsulosin may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Tamsulosin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CA15, gepefrine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Gepefrine.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N03AD01, ethosuximide, The risk or severity of hypotension can be increased when Tamsulosin is combined with Ethosuximide.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Tamsulosin.]
[C01CA01, etilefrine, The therapeutic efficacy of Etilefrine can be decreased when used in combination with Tamsulosin.]
[N01AX07, etomidate, The therapeutic efficacy of Etomidate can be decreased when used in combination with Tamsulosin.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Tamsulosin.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Tamsulosin.]
[R06AX12, terfenadine, The metabolism of Tamsulosin can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Tamsulosin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The metabolism of Tamsulosin can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Tamsulosin can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Tamsulosin.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Tamsulosin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Tamsulosin may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C08CA02, felodipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of hypotension can be increased when Tamsulosin is combined with Fendiline.]
[N03AX26, fenfluramine, The metabolism of Tamsulosin can be decreased when combined with Fenfluramine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Tamsulosin.]
[N02AB03, fentanyl, Tamsulosin may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, The therapeutic efficacy of Salbutamol can be decreased when used in combination with Tamsulosin.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tamsulosin.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[G04BD02, flavoxate, Tamsulosin may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Tamsulosin.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Tamsulosin can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Tamsulosin may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Tamsulosin may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Flunarizine.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Tamsulosin.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AB03, fluoxetine, The serum concentration of Tamsulosin can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Flupentixol.]
[N05AB02, fluphenazine, The metabolism of Tamsulosin can be decreased when combined with Fluphenazine.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05AG01, fluspirilene, The risk or severity of hypotension can be increased when Tamsulosin is combined with Fluspirilene.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S02AA17, fosfomycin, Tamsulosin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L01BC03, tegafur, Tamsulosin may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[N06BX17, adrafinil, The therapeutic efficacy of Adrafinil can be decreased when used in combination with Tamsulosin.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Tamsulosin.]
[J05AE10, darunavir, The metabolism of Tamsulosin can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06DA04, galantamine, The metabolism of Tamsulosin can be decreased when combined with Galantamine.]
[C08DA02, gallopamil, The risk or severity of hypotension can be increased when Tamsulosin is combined with Gallopamil.]
[S01AD09, ganciclovir, Tamsulosin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Tamsulosin.]
[C10AB04, gemfibrozil, Tamsulosin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Tamsulosin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A10BJ02, liraglutide, The therapeutic efficacy of Liraglutide can be increased when used in combination with Tamsulosin.]
[N03AD03, methsuximide, The risk or severity of hypotension can be increased when Tamsulosin is combined with Methsuximide.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be increased when used in combination with Tamsulosin.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be increased when used in combination with Tamsulosin.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be increased when used in combination with Tamsulosin.]
[N05CM18, dexmedetomidine, The therapeutic efficacy of Dexmedetomidine can be decreased when used in combination with Tamsulosin.]
[C05AE01, nitroglycerin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nitroglycerin.]
[C02CA04, doxazosin, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C07AB09, esmolol, Esmolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[M01CB04, aurothioglucose, Tamsulosin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Tamsulosin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Tamsulosin.]
[S01EX01, guanethidine, Tamsulosin may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Tamsulosin can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Tamsulosin.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Halothane.]
[N05AH04, quetiapine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.]
[N06BX13, idebenone, Tamsulosin may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin aspart.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Losartan is combined with Tamsulosin.]
[G03DC01, allylestrenol, Tamsulosin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Tamsulosin.]
[R03CC05, hexoprenaline, The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Tamsulosin.]
[J05AG01, nevirapine, The metabolism of Tamsulosin can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hypotension can be increased when Tamsulosin is combined with Nimesulide.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Perindopril.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Tamsulosin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[G04BD06, propiverine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Tamsulosin can be decreased when combined with Hydroxychloroquine.]
[B05AA07, hetastarch, Tamsulosin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, The metabolism of Tamsulosin can be decreased when combined with Hydroxyzine.]
[C02AC06, rilmenidine, The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Tamsulosin.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[B05XA08, sodium acetate, Tamsulosin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Tamsulosin.]
[L01AA06, ifosfamide, Tamsulosin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Sufentanil.]
[N06AA02, imipramine, Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Paclitaxel.]
[R01AD07, tixocortol, Tamsulosin may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be decreased when used in combination with Tamsulosin.]
[L01CE01, topotecan, Tamsulosin may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C02CA02, indoramin, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.]
[A11HA07, inositol, Tamsulosin may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Tamsulosin can be decreased when combined with Milnacipran.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Cyclopentamine.]
[S01XA28, varenicline, Tamsulosin may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The therapeutic efficacy of Sitagliptin can be increased when used in combination with Tamsulosin.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05CH02, ramelteon, Tamsulosin may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[A10BH02, vildagliptin, The therapeutic efficacy of Vildagliptin can be increased when used in combination with Tamsulosin.]
[C10AA06, cerivastatin, The metabolism of Tamsulosin can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, Alprenolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Tamsulosin may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Tamsulosin.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Tamsulosin.]
[R03CC06, isoetharine, The therapeutic efficacy of Isoetharine can be decreased when used in combination with Tamsulosin.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Imidapril.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isoflurane.]
[N04BX02, entacapone, The metabolism of Tamsulosin can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Tamsulosin can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Tamsulosin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Tamsulosin.]
[A10BJ01, exenatide, The therapeutic efficacy of Exenatide can be increased when used in combination with Tamsulosin.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Tamsulosin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Tamsulosin.]
[N06AX18, reboxetine, The metabolism of Tamsulosin can be decreased when combined with Reboxetine.]
[S01AA24, kanamycin, Tamsulosin may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Tamsulosin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Tamsulosin may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Tamsulosin may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Tamsulosin may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, The metabolism of Tamsulosin can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Tamsulosin can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[M02AA10, ketoprofen, The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tamsulosin.]
[L04AA24, abatacept, The metabolism of Tamsulosin can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The therapeutic efficacy of Arbutamine can be decreased when used in combination with Tamsulosin.]
[N04BC09, rotigotine, The metabolism of Tamsulosin can be decreased when combined with Rotigotine.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[N04BB01, amantadine, Tamsulosin may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, Tamsulosin may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Tamsulosin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Tamsulosin is combined with Levodopa.]
[S02DA01, lidocaine, The metabolism of Tamsulosin can be decreased when combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Lidoflazine.]
[S01AA21, amikacin, Tamsulosin may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The metabolism of Tamsulosin can be decreased when combined with Lisuride.]
[A07DA03, loperamide, The risk or severity of hypotension can be increased when Tamsulosin is combined with Loperamide.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Tamsulosin can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The metabolism of Tamsulosin can be decreased when combined with Temsirolimus.]
[B05XA11, magnesium chloride, Tamsulosin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Tamsulosin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The risk or severity of hypotension can be increased when Tamsulosin is combined with Magnesium sulfate.]
[L01BA05, pralatrexate, Tamsulosin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Tamsulosin can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Tamsulosin may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Mecamylamine.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Tamsulosin.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Tamsulosin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CA11, mephentermine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Mephentermine.]
[N03AB04, mephenytoin, The metabolism of Tamsulosin can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Tamsulosin.]
[N01BB03, mepivacaine, Tamsulosin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Tamsulosin may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Tamsulosin.]
[N05AX13, paliperidone, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.]
[C01CA09, metaraminol, The therapeutic efficacy of Metaraminol can be decreased when used in combination with Tamsulosin.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be increased when used in combination with Tamsulosin.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Tamsulosin.]
[N07BC02, methadone, The metabolism of Tamsulosin can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Metamfetamine.]
[J05AF05, lamivudine, Tamsulosin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Tamsulosin can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Tamsulosin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Tamsulosin.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N02BG08, ziconotide, The risk or severity of hypotension can be increased when Tamsulosin is combined with Ziconotide.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Methotrexate.]
[N05AA02, methotrimeprazine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Methotrimeprazine.]
[C01CA10, methoxamine, The therapeutic efficacy of Methoxamine can be decreased when used in combination with Tamsulosin.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Tamsulosin.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The therapeutic efficacy of Methyldopa can be decreased when used in combination with Tamsulosin.]
[V04CG05, methylene blue, Methylene blue may increase the orthostatic hypotensive activities of Tamsulosin.]
[G03EK01, methyltestosterone, Tamsulosin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The metabolism of Tamsulosin can be decreased when combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The metabolism of Tamsulosin can be decreased when combined with Metoprolol.]
[V04CD01, metyrapone, Tamsulosin may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Tamsulosin can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Tamsulosin.]
[S02AA13, miconazole, The metabolism of Tamsulosin can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CA17, midodrine, The therapeutic efficacy of Midodrine can be decreased when used in combination with Tamsulosin.]
[G03XB01, mifepristone, The therapeutic efficacy of Mifepristone can be increased when used in combination with Tamsulosin.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Valsartan is combined with Tamsulosin.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Tamsulosin.]
[L01XX23, mitotane, The metabolism of Tamsulosin can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Lisdexamfetamine.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tamsulosin.]
[C01BD01, amiodarone, The metabolism of Tamsulosin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Tamsulosin.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Tamsulosin can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Tamsulosin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Tamsulosin can be decreased when combined with Pazopanib.]
[L04AA06, mycophenolic acid, Tamsulosin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Tamsulosin.]
[G04CA04, silodosin, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Silodosin.]
[N06AA17, amoxapine, Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[N03AB05, fosphenytoin, The metabolism of Tamsulosin can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Nadolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[J01CA04, amoxicillin, Tamsulosin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Tamsulosin.]
[V03AB15, naloxone, The metabolism of Tamsulosin can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Tamsulosin can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The therapeutic efficacy of Naphazoline can be decreased when used in combination with Tamsulosin.]
[N06BA01, amphetamine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A10BG01, troglitazone, The therapeutic efficacy of Troglitazone can be increased when used in combination with Tamsulosin.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Tamsulosin is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Tamsulosin.]
[S03AA01, neomycin, Tamsulosin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Remifentanil.]
[A10BX02, repaglinide, The therapeutic efficacy of Repaglinide can be increased when used in combination with Tamsulosin.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Levosimendan.]
[B01AC17, tirofiban, Tamsulosin may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tamsulosin.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[L03AX16, plerixafor, Tamsulosin may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Tamsulosin may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Tamsulosin can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01CE01, inamrinone, Tamsulosin may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Tamsulosin can be decreased when combined with Niacin.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Tamsulosin.]
[C08CA04, nicardipine, Nicardipine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[C04AE02, nicergoline, Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nicotine.]
[C08CA05, nifedipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Nimodipine.]
[C08CA07, nisoldipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Nisoldipine.]
[C08CA08, nitrendipine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Tamsulosin.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05CF03, zaleplon, Tamsulosin may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Tamsulosin.]
[C02DD01, nitroprusside, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Tamsulosin.]
[C01CA03, norepinephrine, The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Tamsulosin.]
[C02KX01, bosentan, Tamsulosin may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[G02CA02, nylidrin, The therapeutic efficacy of Nylidrin can be decreased when used in combination with Tamsulosin.]
[L04AC04, rilonacept, The metabolism of Tamsulosin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Tamsulosin can be decreased when combined with Omeprazole.]
[N02AA02, opium, Tamsulosin may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Tamsulosin.]
[C01DA05, pentaerythritol tetranitrate, Tamsulosin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[J01CF04, oxacillin, Tamsulosin may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[P02BA02, oxamniquine, The metabolism of Tamsulosin can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, Tamsulosin may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, Oxprenolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[N02AA05, oxycodone, The metabolism of Tamsulosin can be decreased when combined with Oxycodone.]
[C01DX03, oxyfedrine, The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Tamsulosin.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Tamsulosin.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Tamsulosin.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05AH05, asenapine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.]
[J04AB30, capreomycin, Tamsulosin may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Papaverine.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Tamsulosin.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[G04BD11, fesoterodine, Tamsulosin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Penbutolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[N05AG03, penfluridol, The risk or severity of hypotension can be increased when Tamsulosin is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Tamsulosin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[S01AA14, penicillin G, Tamsulosin may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Tamsulosin can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Tamsulosin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Tamsulosin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N04BC02, pergolide, The therapeutic efficacy of Pergolide can be decreased when used in combination with Tamsulosin.]
[C08EX02, perhexiline, The metabolism of Tamsulosin can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Tamsulosin can be decreased when combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Tamsulosin.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Tamsulosin.]
[A10BA01, phenformin, The therapeutic efficacy of Phenformin can be increased when used in combination with Tamsulosin.]
[N03AA02, phenobarbital, The metabolism of Tamsulosin can be increased when combined with Phenobarbital.]
[C04AX02, phenoxybenzamine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.]
[A08AA01, phentermine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Phentermine.]
[V03AB36, phentolamine, Phentolamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S01GA05, phenylephrine, The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Tamsulosin.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Tamsulosin.]
[N03AB02, phenytoin, The metabolism of Tamsulosin can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Tamsulosin can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Tamsulosin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Tamsulosin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C08CX01, mibefradil, The risk or severity of hypotension can be increased when Tamsulosin is combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Tamsulosin.]
[C07AA03, pindolol, Pindolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Tamsulosin can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Tamsulosin can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The metabolism of Tamsulosin can be decreased when combined with Pipotiazine.]
[N06BX03, piracetam, Tamsulosin may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Eprosartan.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N02CX01, pizotyline, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Tamsulosin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Irbesartan.]
[A10BG02, rosiglitazone, The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Tamsulosin.]
[L04AC08, canakinumab, The metabolism of Tamsulosin can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Tamsulosin can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The therapeutic efficacy of Saxagliptin can be increased when used in combination with Tamsulosin.]
[B05XA01, potassium chloride, Tamsulosin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Tamsulosin is combined with Insulin lispro.]
[C07AB01, practolol, Practolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[C02CA01, prazosin, Prazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01DX02, prenylamine, The risk or severity of hypotension can be increased when Tamsulosin is combined with Prenylamine.]
[P01BA03, primaquine, The metabolism of Tamsulosin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Tamsulosin can be increased when combined with Primidone.]
[M04AB01, probenecid, Tamsulosin may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Tamsulosin.]
[S01HA05, procaine, Procaine may increase the orthostatic hypotensive activities of Tamsulosin.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Tamsulosin.]
[C10AB05, fenofibrate, Tamsulosin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AB04, prochlorperazine, The metabolism of Tamsulosin can be decreased when combined with Prochlorperazine.]
[G03DA04, progesterone, The metabolism of Tamsulosin can be decreased when combined with Progesterone.]
[N05AA03, promazine, Promazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[R06AD02, promethazine, The metabolism of Tamsulosin can be decreased when combined with Promethazine.]
[C01BC03, propafenone, The metabolism of Tamsulosin can be decreased when combined with Propafenone.]
[A03AB05, propantheline, Tamsulosin may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N05AC01, periciazine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Periciazine.]
[N05CM06, propiomazine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiomazine.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Tamsulosin can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, Propranolol may increase the orthostatic hypotensive activities of Tamsulosin.]
[N02CC04, rizatriptan, Tamsulosin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Epoprostenol.]
[R01BA02, pseudoephedrine, The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Pseudoephedrine.]
[N05AX12, aripiprazole, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.]
[N07XX07, dalfampridine, Tamsulosin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Tamsulosin may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[R06AC01, pyrilamine, The metabolism of Tamsulosin can be decreased when combined with Mepyramine.]
[C01BA01, quinidine, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[P01BC01, quinine, The metabolism of Tamsulosin can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Tamsulosin can be decreased when combined with Ranitidine.]
[C02AA01, rescinnamine, Tamsulosin may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Tamsulosin.]
[J05AP01, ribavirin, Tamsulosin may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Tamsulosin can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, The therapeutic efficacy of Rimiterol can be decreased when used in combination with Tamsulosin.]
[G02CA01, ritodrine, The therapeutic efficacy of Ritodrine can be decreased when used in combination with Tamsulosin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Tamsulosin.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Tamsulosin.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Obinutuzumab.]
[J01GB08, sisomicin, Tamsulosin may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Tamsulosin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Tamsulosin may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Tamsulosin.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
